» Articles » PMID: 15596490

Molecular Modeling of Nearly Full-length ErbB2 Receptor

Overview
Journal Biophys J
Publisher Cell Press
Specialty Biophysics
Date 2004 Dec 15
PMID 15596490
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Members of the epidermal growth factor receptor family play important roles in various cellular processes, both in physiological and in pathological conditions. Dimerization and autophosphorylation of these receptor tyrosine kinases are key events of signal transduction. Details of the molecular events of the signaling are not entirely known. To facilitate the understanding of receptor structure and function at the molecular level, a molecular model was built for the nearly full-length ErbB2 dimer. Modeling was based on the x-ray or nuclear-magnetic resonance structures of extracellular, transmembrane, and intracellular domains. The extracellular domain was positioned above the cell membrane based on the distance determined from experimentally measured fluorescence resonance energy transfer. Favorable dimerization interactions are predicted for the extracellular, transmembrane, and protein kinase domains in the model of a nearly full-length dimer of ErbB2, which may act in a coordinated fashion in ErbB2 homodimerization, and also in heterodimers of ErbB2 with other members of the ErbB family.

Citing Articles

Important Cells and Factors from Tumor Microenvironment Participated in Perineural Invasion.

Chen Z, Fang Y, Jiang W Cancers (Basel). 2023; 15(5).

PMID: 36900158 PMC: 10000249. DOI: 10.3390/cancers15051360.


The combination of trastuzumab and pertuzumab administered at approved doses may delay development of trastuzumab resistance by additively enhancing antibody-dependent cell-mediated cytotoxicity.

Toth G, Szoor A, Simon L, Yarden Y, Szollosi J, Vereb G MAbs. 2016; 8(7):1361-1370.

PMID: 27380003 PMC: 5058622. DOI: 10.1080/19420862.2016.1204503.


Exploring the dynamics and interaction of a full ErbB2 receptor and Trastuzumab-Fab antibody in a lipid bilayer model using Martini coarse-grained force field.

Franco-Gonzalez J, Ramos J, Cruz V, Martinez-Salazar J J Comput Aided Mol Des. 2014; 28(11):1093-107.

PMID: 25129484 DOI: 10.1007/s10822-014-9787-2.


ERBB2 in cat mammary neoplasias disclosed a positive correlation between RNA and protein low expression levels: a model for erbB-2 negative human breast cancer.

Santos S, Baptista C, Abreu R, Bastos E, Amorim I, Gut I PLoS One. 2014; 8(12):e83673.

PMID: 24386251 PMC: 3873372. DOI: 10.1371/journal.pone.0083673.


Simulation of homology models for the extracellular domains (ECD) of ErbB3, ErbB4 and the ErbB2-ErbB3 complex in their active conformations.

Franco-Gonzalez J, Ramos J, Cruz V, Martinez-Salazar J J Mol Model. 2012; 19(2):931-41.

PMID: 23090500 DOI: 10.1007/s00894-012-1613-y.


References
1.
Fleishman S, Schlessinger J, Ben-Tal N . A putative molecular-activation switch in the transmembrane domain of erbB2. Proc Natl Acad Sci U S A. 2002; 99(25):15937-40. PMC: 138543. DOI: 10.1073/pnas.252640799. View

2.
Gerber D, Sal-Man N, Shai Y . Two motifs within a transmembrane domain, one for homodimerization and the other for heterodimerization. J Biol Chem. 2004; 279(20):21177-82. DOI: 10.1074/jbc.M400847200. View

3.
Citri A, Skaria K, Yarden Y . The deaf and the dumb: the biology of ErbB-2 and ErbB-3. Exp Cell Res. 2003; 284(1):54-65. DOI: 10.1016/s0014-4827(02)00101-5. View

4.
Jackson J, St Clair P, Sliwkowski M, Brattain M . Blockade of epidermal growth factor- or heregulin-dependent ErbB2 activation with the anti-ErbB2 monoclonal antibody 2C4 has divergent downstream signaling and growth effects. Cancer Res. 2004; 64(7):2601-9. DOI: 10.1158/0008-5472.can-03-3106. View

5.
Stamos J, Sliwkowski M, Eigenbrot C . Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor. J Biol Chem. 2002; 277(48):46265-72. DOI: 10.1074/jbc.M207135200. View